Federal grants to Xequel Bio, Inc.
Xequel Bio, Inc. in Fort Worth, South Carolina received $3.6 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Military Medical Research and Development, with $2.0 million. In fiscal 2025 more was taken back from its awards than added, a net -$1.5 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.6 million
- Awards6
- Awarded in FY 2025-$1.5 million
- Largest award$1.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $3.2 million |
| FY 2022 | 4 | $5.2 million |
| FY 2023 | 0 | -$874,507 |
| FY 2024 | 0 | -$2.4 million |
| FY 2025 | 0 | -$1.5 million |
Programs that fund Xequel Bio, Inc.
| Program | Awards | Amount |
|---|---|---|
| Military Medical Research and Development | 4 | $2.0 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $1.6 million |
| Vision Research | 1 | $104,724 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Defense | 4 | $2.0 million |
| Department of Health and Human Services | 2 | $1.6 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| COVID-19 restoration of pulmonary barrier function in SARS-COV-2-ASSOCIATED acute respiratory distress syndrome | Military Medical Research and Development | February 11, 2021 | $1.6 million |
| Improving marginal allograft outcomes through cell junction stabilization in transplantation | Diabetes, Digestive, and Kidney Diseases Extramural Research | June 23, 2021 | $1.6 million |
| Therapeutic eye drop for the treatment of corneal injury after chemical burn | Military Medical Research and Development | September 20, 2022 | $776,507 |
| Evaluation of an innovative therapeutic to prevent and/or delay the progression of ali/ards in a non-human primate model | Military Medical Research and Development | September 9, 2022 | $475,391 |
| Evaluation of a connexin-based peptide for the treatment of diabetic retinopathy - diabetic retinopathy (DR) is the leading cause of blindness and visual impairment in us adults. The current standard of care for dr is intravitreal (IVT) injection of anti-vascular endothelial growth factor (VEGF) the | Vision Research | September 8, 2022 | $104,724 |
| Granexin gel to treat pressure ulcers | Military Medical Research and Development | June 24, 2021 | $5,900 |
Questions people ask
How much federal grant money does Xequel Bio, Inc. get?
$3.6 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Xequel Bio, Inc. the most?
The Department of Defense, with $2.0 million in 4 awards. The Department of Health and Human Services follow.
What is Xequel Bio, Inc.'s largest federal grant?
$1.6 million under Military Medical Research and Development, with its first action in the period on February 11, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Xequel Bio, Inc.?
Its largest are Military Medical Research and Development, Diabetes, Digestive, and Kidney Diseases Extramural Research and Vision Research.
Largest federal grant recipients in South Carolina · Federal grants in South Carolina